Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety. - Wikidata - awgldk - TriplyDB

Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety.

Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety.

http://www.wikidata.org/entity/Q34414358

about

Temperament type specific metabolite profiles of the prefrontal cortex and serum in cattle A common and unstable copy number variant is associated with differences in Glo1 expression and anxiety-like behavior Glyoxalase 1 increases anxiety by reducing GABAA receptor agonist methylglyoxal Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches Connecting Anxiety and Genomic Copy Number Variation: A Genome-Wide Analysis in CD-1 Mice Fluoxetine normalizes disrupted light-induced entrainment, fragmented ultradian rhythms and altered hippocampal clock gene expression in an animal model of high trait anxiety- and depression-related behavior 50 years of hurdles and hope in anxiolytic drug discovery Effect of social odor context on the emission of isolation-induced ultrasonic vocalizations in the BTBR T+tf/J mouse model for autism.Potential contribution of oxidative stress and inflammation to anxiety and hypertension Profiling trait anxiety: transcriptome analysis reveals cathepsin B (Ctsb) as a novel candidate gene for emotionality in mice Enhanced fear expression in a psychopathological mouse model of trait anxiety: pharmacological interventions Sex differences in avoidance behavior after perceiving potential risk in mice.Glycogen synthase kinase-3β inhibition in the medial prefrontal cortex mediates paradoxical amphetamine action in a mouse model of ADHD.Developmental delays and reduced pup ultrasonic vocalizations but normal sociability in mice lacking the postsynaptic cell adhesion protein neuroligin2.Individual differences and the characterization of animal models of psychopathology: a strong challenge and a good opportunity.Co-segregation of hyperactivity, active coping styles, and cognitive dysfunction in mice selectively bred for low levels of anxiety.The age of anxiety: role of animal models of anxiolytic action in drug discovery.The clinical implications of mouse models of enhanced anxiety.Anxiety- rather than depression-like behavior is associated with adult neurogenesis in a female mouse model of higher trait anxiety- and comorbid depression-like behavior.Circadian abnormalities in a mouse model of high trait anxiety and depression Differential stress-induced neuronal activation patterns in mouse lines selectively bred for high, normal or low anxiety.Stable isotope metabolic labeling with a novel N-enriched bacteria diet for improved proteomic analyses of mouse models for psychopathologies.A hypomorphic vasopressin allele prevents anxiety-related behavior.The diagnosis of depression: current and emerging methods.The role of proteomics in depression research Sleep phenotyping in a mouse model of extreme trait anxiety.The endocrine stress response is linked to one specific locus on chromosome 3 in a mouse model based on extremes in trait anxiety Increased conditioned place preference for cocaine in high anxiety related behavior (HAB) mice is associated with an increased activation in the accumbens corridor Altered GABA transmission in a mouse model of increased trait anxiety Depression, anxiety-like behavior and memory impairment are associated with increased oxidative stress and inflammation in a rat model of social stress.Glyoxalase I polymorphism rs2736654 causing the Ala111Glu substitution modulates enzyme activity--implications for autism.A mouse model of high trait anxiety shows reduced heart rate variability that can be reversed by anxiolytic drug treatment.Magnesium deficiency induces anxiety and HPA axis dysregulation: modulation by therapeutic drug treatment.Intranasally applied neuropeptide S shifts a high-anxiety electrophysiological endophenotype in the ventral hippocampus towards a "normal"-anxiety one.Proteomic and metabolomic profiling of a trait anxiety mouse model implicate affected pathways Intranasally administered neuropeptide S (NPS) exerts anxiolytic effects following internalization into NPS receptor-expressing neurons.Recent advances in neuroproteomics Effect of an anti-depressant on mouse hippocampus protein turnover using MIMS Role of Glyoxalase 1 (Glo1) and methylglyoxal (MG) in behavior: recent advances and mechanistic insights.

P2860

Q21090552-A2C1E851-614E-48CF-BE03-18BE6252EC1B Q21143860-2467F8A6-160F-4A5A-A63A-B805A045D7C1 Q24613178-F88A316B-546C-4B3F-8FC3-5A902D294E4D Q24632901-4BC30B2B-4E9E-454D-A8FF-5C4A16494FCC Q26738789-817D8DA1-9DAD-4782-A077-A43B6038CA2F Q27305223-70A270E5-6CEA-4D74-9EE1-E3C717EA937D Q27334757-DF16FBFC-6CB4-4316-B081-3A6FF5F22B94 Q28297569-B456D639-1068-40B3-B1FC-D2286BBC198C Q28390065-5396D75D-64B7-4598-8E56-105585068ED9 Q28576099-EAD858B0-35A6-4E1B-B18F-F142C3888196 Q28740918-241109E3-2ECF-493D-9C24-417895F14EF1 Q28742346-46D1E270-C097-49A9-8BD8-E88071BD80ED Q29994823-89EF1850-4187-4F54-91B0-719B868C6614 Q30414710-26CF2117-4513-4228-9D9F-565334ADE368 Q30432899-8A0E0360-6E34-4C59-B07F-CDC965192EAF Q30446936-3F185B5C-3AD8-4B0C-B6A3-5F0DD9CB0A1C Q30450488-B00813B3-6E72-43A0-9687-2E8587957866 Q30462832-D3B917F1-32E7-4587-8E10-9C4B6C1C80B2 Q30474232-9E592A1C-E2C4-4FD9-A397-F41635D7B55C Q30534769-DFFD032D-E659-45F6-8AA2-142E14CF15BC Q30578416-88135C42-D6B3-41F1-ABB4-07D0C702B4CE Q30862113-62A9FEB8-D102-41F2-B229-550854FB1549 Q30886114-E54FE7BC-F573-41E1-A406-3FEA5F1EAB2F Q33428525-EF1DBEFC-BD5F-4DE6-B8FE-327385B46F9A Q33887233-6CCFD373-AD45-4142-BB4B-A6AAF2D4E251 Q34130553-83CCE0E2-33C8-497B-AF08-19094606897E Q34342192-B2B75AD9-08C2-425C-9B74-2730A0B240C6 Q34462860-B6EB3C98-F8EE-4CD7-B77A-87303C525C2F Q34755577-E5739F73-460A-4AF6-8D26-50982C222106 Q34976116-963F69BF-96D6-442E-A15C-D8DF7A983A04 Q35047703-FA989B3A-F20B-4A59-9A7C-377D6DAE8C5D Q35112759-8D647E54-D29D-4CFC-9EA9-35F974D59CD5 Q35406578-3A856351-FAC0-47EF-A46E-599FC04890B7 Q35415126-AB58BC6C-9EB9-4C48-BCFB-AD82B4B6BC8D Q35591938-3E240C5F-D64A-4989-9FCA-BE0ACD19BEB5 Q35610645-B13E7791-06F1-4A1E-ABBA-A0AA4B43ED55 Q35892698-06B29045-A247-42C4-A574-6F74083C8E17 Q36027996-C75A80CF-8C1C-4D06-84A8-CA25D7298FB1 Q36049655-F8983ABE-2BF0-4DC2-94B7-40D0C9924A61 Q36407601-8BF6751E-F098-4C90-9D75-91441356D86B

P2860

Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety.

http://www.wikidata.org/entity/Q34414358

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Identification of glyoxalase-I ...... of extremes in trait anxiety.

@ast

Identification of glyoxalase-I ...... of extremes in trait anxiety.

@en

Identification of glyoxalase-I ...... of extremes in trait anxiety.

@nl

type

label

Identification of glyoxalase-I ...... of extremes in trait anxiety.

@ast

Identification of glyoxalase-I ...... of extremes in trait anxiety.

@en

Identification of glyoxalase-I ...... of extremes in trait anxiety.

@nl

prefLabel

Identification of glyoxalase-I ...... of extremes in trait anxiety.

@ast

Identification of glyoxalase-I ...... of extremes in trait anxiety.

@en

Identification of glyoxalase-I ...... of extremes in trait anxiety.

@nl

P1433

Q34414358-5E3B50CF-1248-4C44-8CB8-0A43D11CAFB6

P1476

Q34414358-DB892DCB-0C65-4FDE-B22E-0C98238B434A

P2093

Q34414358-1D858F0E-9C77-4C06-9399-3A13A3160D24

Q34414358-332B8CE4-CFAE-4FC9-9970-0A74CD72480F

Q34414358-3B902797-7302-4898-B593-FE4F5087015A

Q34414358-40559932-765E-4564-B5E1-6E762D29A31D

Q34414358-732E2A5E-1C31-43E9-9089-CD8B3F53474C

Q34414358-788B549E-6D1B-4AF6-A14F-C99384774EA7

Q34414358-7A20D3DF-B9DE-4707-858D-D495AABD444F

Q34414358-9089E54A-8D42-4856-BF64-A50970A75755

Q34414358-ABDD1F04-7697-4E25-8C70-B7E1CE1D3F2C

P304

Q34414358-0D579D50-0B1A-4F65-9AA3-6C22706EFF06

P31

Q34414358-34635F96-FEB1-402A-BAD3-D087A529E9E9

P356

Q34414358-E02DEE12-7990-4370-91B2-7CA62B914EB4

P407

Q34414358-26EB7095-D208-42DC-A3C3-334BAE6C8191

P433

Q34414358-302AADC6-E09D-43AA-996F-B84F5BB2B238

P478

Q34414358-8C29808F-5B3E-4E28-813C-B8B8AC18974F

P50

Q34414358-0548D8F2-CCD6-4155-8FC2-CEC66E683A1A

Q34414358-66C68631-3E07-49A4-A926-1FD22FEA879D

Q34414358-D055A7B5-C3F2-44A3-BB9D-ED0CCFCBFACF

P577

Q34414358-1F4E3BC5-ED03-4271-9D7B-841DB1B94FA8

P698

Q34414358-966CA4BA-F8A0-42FF-A764-04D23DB67F2B

P932

Q34414358-179860F0-4A7F-46B4-A301-E157E1B404E7

P356

JNEUROSCI.0115-05.2005

P1433

Journal of Neuroscience

P1476

Identification of glyoxalase-I ...... l of extremes in trait anxiety

@en

P2093

Christoph W Turck

http://www.w3.org/2001/XMLSchema#string

Dale Milfay

http://www.w3.org/2001/XMLSchema#string

Florian Holsboer

http://www.w3.org/2001/XMLSchema#string

Isabel N Birg

http://www.w3.org/2001/XMLSchema#string

Markus Panhuysen

http://www.w3.org/2001/XMLSchema#string

Melanie S Kessler

http://www.w3.org/2001/XMLSchema#string

Mirjam Bunck

http://www.w3.org/2001/XMLSchema#string

Rainer Landgraf

http://www.w3.org/2001/XMLSchema#string

Simone A Krömer

http://www.w3.org/2001/XMLSchema#string

P304

4375-4384

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1523/JNEUROSCI.0115-05.2005

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Jan M. Deussing

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15858064

http://www.w3.org/2001/XMLSchema#string

P932

6725100

http://www.w3.org/2001/XMLSchema#string